Chugai Pharmaceutical Co. Ltd. - Capital Expenditures

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Capital-Expenditures" stands at 59.22 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of 9.98 Billion JPY for the item "Capital Expenditures" represents a decrease of -62.81 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of 9.98 Billion JPY for the item "Capital Expenditures" represents a decrease of -43.07 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of 59.22 Billion JPY for the item "Capital Expenditures" represents a decrease of -11.30 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -13.89 percent compared to the value the year prior.
The 1 year change in percent is -13.89.
The 3 year change in percent is -11.72.
The 5 year change in percent is -29.47.
The 10 year change in percent is 124.86.

The Serie's long term average value is 48.76 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 21.45 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2013, to it's latest available value, on 09/30/2025, is +295.74%.
The Serie's change in percent from it's maximum value, on 06/30/2020, to it's latest available value, on 09/30/2025, is -33.24%.